TABLE 3.
Authors (Year) | Manipulation/Drug Type | Drug Name | Behavioral Paradigm | Measure of Fear | Observation |
---|---|---|---|---|---|
Marsicano et al (2002)64 | CB1 gene knockout | N/A | Extinction of conditioned fear (cue) | Conditioned freezing | Impairment of extinction |
Chhatwal et al (2005)66 | CB1 agonist | WIN 55,212-2 | Extinction of conditioned fear (cue) | Fear-potentiated startle | No effect |
Suzuki et al (2004)76 | CB1 antagonist | Rimonabant | Extinction of conditioned fear (context) | Conditioned freezing | Impairment of extinction |
Marsicano et al (2002)64 | CB1 antagonist | Rimonabant | Extinction of conditioned fear (cue) | Conditioned freezing | Impairment of extinction |
Chhatwal et al (2005)66 | CB1 antagonist | Rimonabant | Extinction of conditioned fear (cue) | Fear-potentiated startle | Impairment of extinction |
Chhatwal et al (2005)66 | FAAH inhibitor, eCB reuptake inhibitor | AM404 | Extinction of conditioned fear (cue) | Fear-potentiated startle | Enhancement of extinction |
eCB=endogenous cannabinoid; CB1=cannabinoid-type 1; N/A=not applicable; FAAH=fatty acid amide hydrolase.
Chhatwal JP, Ressler KJ.